20-59300823-G-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_207034.3(EDN3):c.11G>C(p.Gly4Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,611,322 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_207034.3 missense
Scores
Clinical Significance
Conservation
Publications
- Waardenburg syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Waardenburg syndrome type 4BInheritance: AR, AD, SD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, PanelApp Australia, G2P
- Waardenburg-Shah syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hirschsprung disease, susceptibility to, 4Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000144 AC: 22AN: 152252Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000454 AC: 11AN: 242094 AF XY: 0.0000151 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1458952Hom.: 1 Cov.: 31 AF XY: 0.00000827 AC XY: 6AN XY: 725766 show subpopulations
GnomAD4 genome AF: 0.000144 AC: 22AN: 152370Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74516 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1433645). This variant has not been reported in the literature in individuals affected with EDN3-related conditions. This variant is present in population databases (rs202140125, gnomAD 0.07%). This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 4 of the EDN3 protein (p.Gly4Ala). -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Uncertain:1
The c.11G>C (p.G4A) alteration is located in exon 1 (coding exon 1) of the EDN3 gene. This alteration results from a G to C substitution at nucleotide position 11, causing the glycine (G) at amino acid position 4 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at